About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: October 08, 2010
    The Gulf of Mexico oil spill is unprecedented in its size and duration, as were the use of chemical dispersants and controlled burns to remove the oil. The National Institute of Environmental Health Sciences (NIEHS) is developing a study protocol to investigate the health effects on clean-up workers. The IOM held a workshop to review and comment on NIEHS’s study protocol.
  • Released: October 08, 2010
    The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA’s science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.
  • Released: October 07, 2010
    In 2003, the Department of Homeland Security (DHS) introduced the BioWatch program—a federal monitoring system intended to speed detection of specific biological agents that could be released in aerosolized form during a biological attack. A report by the IOM and the National Research Council evaluates the costs and merits of the BioWatch program, examines infectious disease surveillance through U.S. hospitals and public health agencies, and considers whether BioWatch and traditional infectious disease surveillance are redundant or complementary.
  • Released: October 05, 2010
    The United States has the opportunity to transform its health care system, and nurses, as the largest segment of the nation’s health care workforce, can and should play a fundamental role in this transformation. In this report the IOM makes recommendations for an action-oriented blueprint for the future of nursing.
  • Released: October 04, 2010
    Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development.
  • Released: September 23, 2010
    Over the past two decades, there have been major changes in government support of women’s health research. The IOM finds that women’s health research has contributed to significant progress in lessening the burden of disease and reducing deaths from some conditions, while other conditions have seen only moderate change or even little or no change.
  • Released: September 16, 2010
    More than two hundred thousand people in the United States living with HIV/AIDS do not know they are infected. The IOM’s Committee on HIV Screening and Access to Care held a workshop and reviewed literature to explore barriers and facilitators to more widespread HIV testing. This report contains the committee’s conclusions.
  • Released: September 13, 2010
    The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus qualify for disability benefits. In this report, the IOM makes several recommendations for improving SSA’s capacity for determining disability benefits more accurately and quickly using the HIV Infection Listings.
  • Released: September 08, 2010
    Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of blood samples for translational research.
  • Released: September 07, 2010
    Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant “superbugs.” The IOM’s Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
Buy Buy Nolvanox online

steroid-pharm.com/